Inadequacy of clinical trial designs and data to control for the confounding impact of race/ethnicity in response to treatment in multiple sclerosis
JAMA Neurol
.
2014 Aug;71(8):943-4.
doi: 10.1001/jamaneurol.2014.79.
Author
Jagannadha Avasarala
1
Affiliation
1
Cape Neurology Specialists, St Francis Medical Center, Cape Girardeau, Missouri.
PMID:
24911916
DOI:
10.1001/jamaneurol.2014.79
No abstract available
MeSH terms
Black or African American*
Clinical Trials as Topic / standards*
Humans
Multiple Sclerosis / drug therapy*
Patient Selection*
Treatment Outcome*